DOP2013000214A - Derivados novedosos de cefalosporinas y composiciones farmaceuticas de estos - Google Patents

Derivados novedosos de cefalosporinas y composiciones farmaceuticas de estos

Info

Publication number
DOP2013000214A
DOP2013000214A DO2013000214A DO2013000214A DOP2013000214A DO P2013000214 A DOP2013000214 A DO P2013000214A DO 2013000214 A DO2013000214 A DO 2013000214A DO 2013000214 A DO2013000214 A DO 2013000214A DO P2013000214 A DOP2013000214 A DO P2013000214A
Authority
DO
Dominican Republic
Prior art keywords
derivatives
present
cephalosporins
noveled
prodrug
Prior art date
Application number
DO2013000214A
Other languages
English (en)
Inventor
Young Lag Cho
Joung Yul Yun
Chul Soon Park
Sang Eun Chae
Hyang Sook Lee
Kyuman Oh
Hye Jin Heo
Dae Hyuck Kang
Young Jae Yang
Hyun Jin Kwon
Tae Kyo Park
Sung Ho Woo
Yong Zu Kim
Original Assignee
Legochem Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Legochem Biosciences Inc filed Critical Legochem Biosciences Inc
Publication of DOP2013000214A publication Critical patent/DOP2013000214A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/60—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 3 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

La presente invención se refiere a derivados novedosos de cefalosporinas representados por la fórmula química 1. Donde X, Y, L, R1 y R2 son los mismos que se han definido en la descripción de la invención. La presente invención tambión se refiere a composiciones antibióticas farmacéuticas que comprenden un derivado novedoso de cefalosporinas representado par la formula química 1, un profarmaco de este, un hidrato de este, un solvato de este, un isómero de este a una sal farmacéuticamente aceptable de este como principio eficaz. De acuerdo con la presente invención, los derivados novedosos de cefalosporinas, un profarmaco de estos, un hidrato de estos, un solvato de estos, un isómero de estos o una sal farmacéuticamente aceptable de estos pueden ser útiles como antibióticos debido a su amplio espectro contra bacterias resistentes a antibióticos, su baja toxicidad y especialmente su potente efecto antibacteriano en bacterias gramnegativas.
DO2013000214A 2011-03-30 2013-09-27 Derivados novedosos de cefalosporinas y composiciones farmaceuticas de estos DOP2013000214A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020110028603A KR101719556B1 (ko) 2011-03-30 2011-03-30 신규한 세파로스포린 유도체 및 이를 함유하는 의약 조성물

Publications (1)

Publication Number Publication Date
DOP2013000214A true DOP2013000214A (es) 2013-12-15

Family

ID=46932135

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2013000214A DOP2013000214A (es) 2011-03-30 2013-09-27 Derivados novedosos de cefalosporinas y composiciones farmaceuticas de estos

Country Status (27)

Country Link
US (2) US8329684B2 (es)
EP (1) EP2706062B1 (es)
JP (1) JP6144669B2 (es)
KR (1) KR101719556B1 (es)
CN (1) CN103547583B (es)
AU (1) AU2012237063B2 (es)
BR (1) BR112013025275A2 (es)
CA (1) CA2831421C (es)
CL (1) CL2013002820A1 (es)
CO (1) CO6821935A2 (es)
CR (1) CR20130501A (es)
CU (1) CU20130125A7 (es)
DK (1) DK2706062T3 (es)
DO (1) DOP2013000214A (es)
EA (1) EA024709B1 (es)
ES (1) ES2683351T3 (es)
HR (1) HRP20181170T1 (es)
HU (1) HUE039086T2 (es)
IL (1) IL228408A (es)
LT (1) LT2706062T (es)
MX (1) MX359435B (es)
PL (1) PL2706062T3 (es)
PT (1) PT2706062T (es)
SG (1) SG193998A1 (es)
SI (1) SI2706062T1 (es)
WO (1) WO2012134184A2 (es)
ZA (1) ZA201308078B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2702257C (en) 2007-10-09 2016-07-12 Sopharmia, Inc. Broad spectrum beta-lactamase inhibitors
JP2017527604A (ja) 2014-09-17 2017-09-21 アイアンウッド ファーマシューティカルズ インコーポレイテッド ｓＧＣ刺激剤
US10059680B2 (en) * 2014-12-18 2018-08-28 Merck Sharp & Dohme Corp. Thiadiazolyl-oximinoacetic acid derivative compounds
US20160176897A1 (en) 2014-12-23 2016-06-23 Merck Sharp & Dohme Corp. 7-aminocephem derivative compounds
AU2016367284C1 (en) 2015-12-10 2018-09-20 Naeja-Rgm Pharmaceuticals Ulc Cephem compounds, their production and use
EP3526225A1 (en) * 2016-10-14 2019-08-21 Universidade do Porto Hydroxycinnamic derivatives, methods and uses thereof
KR20180093307A (ko) * 2017-02-13 2018-08-22 주식회사 레고켐 바이오사이언스 4, 5-디아미노 치환 피리미딘 유도체의 제조방법 및 이를 제조하기 위한 신규한 화합물
WO2019145784A2 (en) * 2018-01-26 2019-08-01 Legochem Biosciences, Inc. Combination therapies for multi-drug resistant pathogens
CN109762791B (zh) * 2018-11-19 2021-02-09 厦门联合安金生物工程有限公司 包含BPI-Fc嵌合基因的重组腺病毒及其用途
CN111471058A (zh) * 2019-01-23 2020-07-31 中国医学科学院药物研究所 用于制备头孢吡普类似物的方法
US20220332728A1 (en) 2019-09-06 2022-10-20 Nabriva Therapeutics GmbH Siderophore cephalosporin conjugates and uses thereof
CN111635377A (zh) * 2020-06-30 2020-09-08 南京红杉生物科技有限公司 噻二唑类化合物及其合成方法
KR20220152157A (ko) * 2021-05-07 2022-11-15 한국생명공학연구원 신규 사이드로포어 화합물 및 이를 이용한 금속 나노입자 복합체

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3006888A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
EP0303172A3 (de) * 1987-08-14 1991-05-15 F. Hoffmann-La Roche Ag Oxyimino-Cephalosporine
GB8817653D0 (en) * 1988-07-25 1988-09-01 Fujisawa Pharmaceutical Co New cephem compounds & processes for preparation thereof
GB9111406D0 (en) * 1991-05-28 1991-07-17 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
US5498777A (en) * 1994-07-20 1996-03-12 Merck & Co., Inc. 3-thioheteroaryl cephalosporin compounds, compositions and methods of use
TW200305422A (en) * 2002-03-18 2003-11-01 Shionogi & Co Broad spectrum cefem compounds
JP4555823B2 (ja) * 2003-07-11 2010-10-06 セラヴァンス， インコーポレーテッド 架橋されたグリコペプチド−セファロスポリン抗生物質
JPWO2005085258A1 (ja) * 2004-03-05 2007-12-13 塩野義製薬株式会社 ３−ピリジニウムメチルセフェム化合物
AU2005202802A1 (en) * 2004-06-28 2006-01-12 Astellas Pharma Inc. Cephem compounds
CN101230070A (zh) * 2006-12-30 2008-07-30 黄振华 新型抗感染头孢类化合物
RS55365B1 (sr) * 2008-10-31 2017-03-31 Shionogi & Co Cefalosporin sa kateholskom grupom

Also Published As

Publication number Publication date
SI2706062T1 (sl) 2018-11-30
JP6144669B2 (ja) 2017-06-07
CO6821935A2 (es) 2013-12-31
US20120264727A1 (en) 2012-10-18
MX359435B (es) 2018-09-28
CA2831421A1 (en) 2012-10-04
CR20130501A (es) 2014-05-13
EP2706062A2 (en) 2014-03-12
DK2706062T3 (en) 2018-08-06
EA201391325A1 (ru) 2014-04-30
ES2683351T3 (es) 2018-09-26
HUE039086T2 (hu) 2018-12-28
PT2706062T (pt) 2018-09-28
EA024709B1 (ru) 2016-10-31
US20130178455A1 (en) 2013-07-11
CL2013002820A1 (es) 2014-04-11
CN103547583B (zh) 2016-11-16
KR20120110625A (ko) 2012-10-10
KR101719556B1 (ko) 2017-03-24
CU20130125A7 (es) 2014-03-26
MX2013010961A (es) 2014-03-27
SG193998A1 (en) 2013-11-29
JP2014510750A (ja) 2014-05-01
WO2012134184A2 (ko) 2012-10-04
PL2706062T3 (pl) 2018-11-30
IL228408A0 (en) 2013-12-31
WO2012134184A3 (ko) 2013-03-07
HRP20181170T1 (hr) 2018-11-02
WO2012134184A8 (ko) 2013-10-24
BR112013025275A2 (pt) 2016-12-13
US8329684B2 (en) 2012-12-11
CN103547583A (zh) 2014-01-29
ZA201308078B (en) 2019-01-30
CA2831421C (en) 2019-06-04
EP2706062B1 (en) 2018-05-09
AU2012237063B2 (en) 2017-03-16
IL228408A (en) 2017-01-31
EP2706062A4 (en) 2015-01-21
AU2012237063A1 (en) 2013-10-17
LT2706062T (lt) 2018-10-25
US9630977B2 (en) 2017-04-25

Similar Documents

Publication Publication Date Title
DOP2013000214A (es) Derivados novedosos de cefalosporinas y composiciones farmaceuticas de estos
UY33316A (es) Compuestos de cefemo que contienen seudocatecol
DOP2014000212A (es) Compuestos inhibidores de beta-lactamasas
ECSP14013273A (es) Compuestos antibacterianos y métodos para su uso
ECSP16073620A (es) Compuestos organicos de monobactam para el tratamiento de infecciones bacterianas
AU2012302022A8 (en) Antibacterial compounds and methods for use
CO6620055A2 (es) Ciertas amino-pirimidinas, composiciones de las mismas y métodos para el uso de los mismos
CR11683A (es) Piridinas y pirazinas como inhibidores de p13k
GEP20156370B (en) Fluoro-pyridinone derivatives useful as antibacterial agents
AR100006A1 (es) Derivados de tubulisina
NZ593892A (en) Antibiotic compositions for the treatment of gram negative infections
EA201490634A1 (ru) Производные полимиксина
CO2019002624A2 (es) Compuestos antibióticos
UY35295A (es) ?Compuestos microbicidas novedosos, métodos para su uso y composiciones?.
AR074833A1 (es) Agentes lipopeptidicos antibacterianos para el tratamiento de infecciones con grampositivos
SG10201900541QA (en) Derivatives of xanthone compounds
CL2017001276A1 (es) Derivados de benzotiazol antibacterianos
WO2015024021A3 (en) Antibacterial compounds
BR112013024497A2 (pt) novo derivado de oxazolidinona e composição farmacêutica incluindo o mesmo
PE20190459A1 (es) Inhibidores de beta-lactamasa
AR088735A1 (es) Compuestos de tienopirimidina que son inhibidores de canal de potasio
ECSP13012902A (es) Derivados novedosos de cefalosporinas y composiciones farmacéuticas de estos
ES2506715A1 (es) Compuestos peptídicos útiles como agentes antibióticos
GEP20186874B (en) Hydrochloride salts of an antibiotic compound
EA202190444A1 (ru) Диазабициклооктаноны в качестве ингибиторов сериновых бета-лактамаз